肾素-血管紧张素系统失衡可能促进IBD炎症和纤维化:一个新治疗靶点?
该研究评估肾素-血管紧张素系统(RAS)对肠道炎症和纤维化的影响:体外实验显示Ang(1-7)和卡托普利减少人结肠肌成纤维细胞增殖和胶原分泌,Ang II增加胶原分泌;IBD患者循环肾素和ACE2:ACE比值高于对照;回顾性研究显示需手术或住院的IBD患者较少使用ACEI/ARB。结论认为RAS介导纤维化、在肠道炎症中失调,靶向该系统的药物与改善疾病结局相关。
要点
- Ang(1-7)剂量依赖性减少人结肠肌成纤维细胞增殖(p<0.05),Ang II仅轻微增加增殖。
- IBD患者循环肾素(均值25.4 vs 18.6 mIU/L,p=0.026)和ACE2:ACE比值(均值0.92 vs 0.69,p=0.015)高于无IBD对照。
- 需手术的IBD患者使用ACEI/ARB比例低于不需手术者(1/37 vs 12/75,p=0.034)。
核心结论
- RAS在人细胞培养中介导纤维化,在肠道表达并在肠道炎症中失调,靶向该系统的药物与改善疾病结局相关。
研究设计与样本
- 体外培养人结肠肌成纤维细胞实验,评估Ang II、Ang(1-7)、坎地沙坦、A779和卡托普利对增殖和胶原分泌的影响。
- 检测IBD患者与无IBD对照的循环和肠道RAS组分。
- 回顾性研究评估接受ACEI/ARB治疗的IBD患者的疾病结局。
主要发现
- Ang(1-7)剂量依赖性减少人结肠肌成纤维细胞增殖(p<0.05),坎地沙坦逆转Ang II对增殖的轻微增加效应(p<0.001)。
- Ang(1-7)(p<0.05)和卡托普利(p<0.001)减少结肠肌成纤维细胞胶原分泌,Ang II增加胶原分泌(p<0.001)。
- IBD患者循环肾素(均值25.4 vs 18.6 mIU/L,p=0.026)和ACE2:ACE比值(均值0.92 vs 0.69,p=0.015)高于无IBD对照。
- 结肠黏膜Masson三色染色与Ang II正相关(r=0.346,p=0.010),与ACE2活性负相关(r=-0.373,p=0.006)。
- 2年内需手术的IBD患者较不需手术者更少使用ACEI/ARB(1/37 vs 12/75,p=0.034),需住院者较不需住院者更少使用(0/34 vs 8/68,p=0.049)。
关键数值与推荐
- 人结肠肌成纤维细胞增殖:Ang(1-7)剂量依赖性减少(p<0.05),Ang II轻微增加(无显著差异),坎地沙坦逆转Ang II效应(p<0.001)。
- 胶原分泌:Ang(1-7)减少(p<0.05),卡托普利减少(p<0.001),Ang II增加(p<0.001)。
- IBD患者循环肾素均值25.4 vs 对照18.6 mIU/L(p=0.026);ACE2:ACE比值均值0.92 vs 0.69(p=0.015)。
- 结肠黏膜Masson三色染色与Ang II相关(r=0.346,p=0.010),与ACE2活性负相关(r=-0.373,p=0.006)。
- 2年结局:需手术者ACEI/ARB使用1/37 vs 不需手术者12/75(p=0.034);需住院者0/34 vs 不需住院者8/68(p=0.049)。
临床怎么用
- 该研究为观察性及体外研究,提示RAS可能作为IBD炎症和纤维化的治疗靶点,但尚需进一步研究验证。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated the influence of the renin-angiotensin system (RAS) on intestinal inflammation and fibrosis. DESIGN: Cultured human colonic myofibroblast proliferation and collagen secretion were assessed following treatment with angiotensin (Ang) II and Ang (1-7), their receptor antagonists candesartan and A779, and the ACE inhibitor captopril. Circulating and intestinal RAS components were evaluated in patients with and without IBD. Disease outcomes in patients with IBD treated with ACE inhibitors and angiotensin receptor blockers (ARBs) were assessed in retrospective studies. RESULTS: Human colonic myofibroblast proliferation was reduced by Ang (1-7) in a dose-dependent manner (p<0.05). Ang II marginally but not significantly increased proliferation, an effect reversed by candesartan (p<0.001). Colonic myofibroblast collagen secretion was reduced by Ang (1-7) (p<0.05) and captopril (p<0.001), and was increased by Ang II (p<0.001). Patients with IBD had higher circulating renin (mean 25.4 vs 18.6 mIU/L, p=0.026) and ACE2:ACE ratio (mean 0.92 vs 0.69, p=0.015) than controls without IBD. RAS gene transcripts and peptides were identified in healthy and diseased bowels. Colonic mucosal Masson's trichrome staining correlated with Ang II (r=0.346, p=0.010) and inversely with ACE2 activity (r=-0.373, p=0.006). Patients with IBD who required surgery (1/37 vs 12/75, p=0.034) and hospitalisation (0/34 vs 8/68, p=0.049) over 2 years were less often treated with ACE inhibitors and ARBs than patients not requiring surgery or hospitalisation. CONCLUSIONS: The RAS mediates fibrosis in human cell cultures, is expressed in the intestine and perturbed in intestinal inflammation, and agents targeting this system are associated with improved disease outcomes.
引用
- Garg M, Royce SG, Tikellis C, et al. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut. 2019. PMID: 31409604. doi:10.1136/gutjnl-2019-318512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。